Business Standard

US presidential election results may not impact Indian pharma industry

Europe, not India, will be the 1st target if US reduces import dependence: Experts

pharma sector
Premium

Indian players such as Sun Pharma and Lupin have large-scale manufacturing plants in the US too.

Sohini Das Mumbai
As the battle for the White House is heading for a photo finish, Indian pharma industry veterans point out that the election outcome is unlikely to have any significant impact on the local pharmaceutical players.

The prime reason is while the US, just like other countries, is trying to lessen dependence on imports for essential drugs, the Indian industry feels they are likely to take a balanced approach when it comes to sourcing.

Veterans like Cadila Healthcare Chairman Pankaj Patel and Dr Reddy’s Laboratories Chairman Satish Reddy said it was too early to comment.

According to Uday Bhaskar, director general of the Pharmaceutical

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in